Drug
How Does Specialty Drug Use Vary Among Employer-Sponsored Health Plans?
…adherence patterns. Employees were divided into subgroups based on their race and ethnicity as per employer-provided data. Wage data was use...
The Effects of Drug Control Policies on Individual and Community Health for People of Color
The United States has a complex system of laws and policies that attempt to regulate the distribution, manufacture, and use of a variety of non-leg...
Characteristics of race/ethnicity in trials leading to anti‐rheumatic drug approval for inflammatory arthritis by the US Food and Drug Administration
…the approved drugs and demographic data for each pivotal trial, especially the race/ethnicity data, were collected. The enrollment profiles ...
Black, Hispanic Alzheimer's patients excluded from new drug testing
New promising treatments for Alzheimer’s disease may not be as beneficial for black and Hispanic sufferers.
Leqembi and donanemab, an experimental...
Trial for multiple sclerosis drug focused on Hispanic and Black patients
Illustration: Annelise Capossela/Axios
Researchers are conducting what they call a first of its kind clinical trial to study how Hispanic and Bla...
Only 1 of 25 cancer drug developers fairly included minority patients over five-year window, BMJ analysis finds
New clinical trial diversity plans, which FDA will soon explain further, were featured in the government spending package that President Joe Biden ...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
